By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Will Washington Prevent a Cure for Cancer?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Health Reform > Will Washington Prevent a Cure for Cancer?
Health Reform

Will Washington Prevent a Cure for Cancer?

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

The United States can rightly claim the title of medicine chest to the world. Almost two-thirds of research on new medicines approved in the last 10 years was performed in this country. Today, the U.S. accounts for 82% of the biotechnology research and development in the world and has over 2,900 medicines in the pipeline. U.S. biopharmaceutical exports rose to $46 billion in 2009 from $29 billion in 2005. [Yet] there are two big public-policy threats on the horizon for Merck … the biopharmaceutical industry.

The United States can rightly claim the title of medicine chest to the world. Almost two-thirds of research on new medicines approved in the last 10 years was performed in this country. Today, the U.S. accounts for 82% of the biotechnology research and development in the world and has over 2,900 medicines in the pipeline. U.S. biopharmaceutical exports rose to $46 billion in 2009 from $29 billion in 2005. [Yet] there are two big public-policy threats on the horizon for Merck … the biopharmaceutical industry. One is the Independent Payment Advisory Board, or IPAB, which originated in last year’s health-reform law. This board has the power to reduce Medicare payments for innovative products simply because overall Medicare costs exceed certain budget targets in any one year. The other harmful proposal on Washington’s agenda would impose price controls for the first time on the Medicare Part D prescription-drug program.

See article on U.S. government regulations that halter medical progress.

   

More Read

Choosing the Right Medicare Plan
Waking Up? GOP Governors Want to Talk to Obama About Health Reform
FDA’s Agenda for 2016: Biggest Issues on Agency’s Calendar for the New Year
ICD-10 Delay: What It Means to You
What Can You Do If Your Long-Term Disability Insurance Won’t Pay Up?
TAGGED:healthcare reformIPABMedicare
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025
Traumatic Brain Injuries
Understanding Traumatic Brain Injuries: What Families Need to Know
Policy & Law
October 10, 2025
Remote Monitoring touchpoints
Remote Monitoring Touchpoints Patients Will Actually Follow
Technology
October 9, 2025

You Might also Like

Defense Sec’y: Medicare, SS Funding Increases Should Be Considered in Wake of More Cuts in Pentagon Budget

August 7, 2011

Tell Your Story: 2013 Costs of Care Essay Contest Is Open!

September 13, 2013

HHS: Insurance Required to Offer Birth Control, Contraceptive Planning

August 1, 2011

Sorry, Captain, There’s No Transparency in Medical Pricing

June 2, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?